Back
Akero Therapeutics Stock Price Chart

Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
21
AKRO
Akero Therapeutics
Last Price:
$40.00
Seasonality Move:
9.58%
7 Day Trial
ALL ACCESS PASS
$
7

Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Akero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.62 | Sell |
20-day SMA: | 43.68 | Sell |
50-day SMA: | 45.6 | Sell |
200-day SMA: | 32.06 | Buy |
8-day EMA: | 42.13 | Sell |
20-day EMA: | 43.64 | Sell |
50-day EMA: | 42.82 | Sell |
200-day EMA: | 34.67 | Buy |
Akero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.09 | Sell |
Relative Strength Index (14 RSI): | 44.55 | Sell |
Chaikin Money Flow: | 1686119 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.16 - 46.5) | Sell |
Bollinger Bands (100): | (27.58 - 47.6) | Buy |
Akero Therapeutics Technical Analysis
Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
-
Akero Therapeutics share price is 41.95 while AKRO 8-day simple moving average is 42.62, which is a Sell signal.
-
The stock price of AKRO is 41.95 while Akero Therapeutics 20-day SMA is 43.68, which makes it a Sell.
-
Akero Therapeutics 50-day simple moving average is 45.60 while AKRO share price is 41.95, making it a Sell technically.
-
AKRO stock price is 41.95 and Akero Therapeutics 200-day simple moving average is 32.06, creating a Buy signal.
AKRO Technical Analysis vs Fundamental Analysis
Sell
21
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a SellThe current Akero Therapeutics [AKRO] share price is $41.95. The Score for AKRO is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
Akero Therapeutics Stock Info
Market Cap:
3.3B
Price in USD:
41.95
Share Volume:
1.7M
Akero Therapeutics 52-Week Range
52-Week High:
58.40
52-Week Low:
17.86
Sell
21
Akero Therapeutics (AKRO)
is a Sell
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?The Akero Therapeutics stock price is 41.95 USD today.
-
Will AKRO stock go up or go down?Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Akero Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is overvalued.
Is Akero Therapeutics Stock a Buy?
-
Akero Therapeutics share price is 41.95 while AKRO 8-day exponential moving average is 42.13, which is a Sell signal.
-
The stock price of AKRO is 41.95 while Akero Therapeutics 20-day EMA is 43.64, which makes it a Sell.
-
Akero Therapeutics 50-day exponential moving average is 42.82 while AKRO share price is 41.95, making it a Sell technically.
-
AKRO stock price is 41.95 and Akero Therapeutics 200-day simple moving average is 34.67, creating a Buy signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.48 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
-
AKRO Moving Average Covergence Divergence (MACD) indicator is -1.09, suggesting Akero Therapeutics is a Sell
-
Akero Therapeutics Relative Strength Index (RSI) is 44.55, which suggest Akero Therapeutics is oversold
-
The Bollinger Bands (25) for Akero Therapeutics is (42.16 - 46.5), which suggest Akero Therapeutics is a Buy
-
The Bollinger Bands (100) for Akero Therapeutics is (27.58 - 47.6), which suggest Akero Therapeutics is a Buy
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.